GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE
- 专利权人:
- INC.;SEATTLE GENETICS
- 发明人:
- Daniel T. Dransfield,Jillian M. Prendergast,David A. Eavarone
- 申请号：
- US16489569
- 公开号：
- US20200000932A1
- 申请日:
- 2018.03.02
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- Methods of treating cancer are provided that include administering glycan-interacting antibodies. Included are anti-sialyl Tn antigen antibodies and related compositions and formulations suitable to achieve desirable bioactivity, bioavailability, and toxicity levels.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Glycan-interacting compounds and methods of use
- Glycan-Interacting Compounds and Methods of Use
- TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND IL-6
- antibody or antigen binding fragment thereof, isolated polypeptide, isolated nucleic acid, expression vector, host cell, composition, methods for producing an antibody or antigen binding fragment for treating cancer and an infection or infectious disease for detecting the presence of a tigit peptide or fragment thereof and for enhancing the activity of an immune cell and the antitumor activity of an anti-tigit antibody, vaccine, and use of an antibody or antigen binding fragment
- Methods for treating urinary epithelial carcinoma using anti-PD-1 antibodies
